BE849475A - Derives etherifies de l'acide clavulanique, leur preparation et compositions en contenant. - Google Patents
Derives etherifies de l'acide clavulanique, leur preparation et compositions en contenant.Info
- Publication number
- BE849475A BE849475A BE173320A BE173320A BE849475A BE 849475 A BE849475 A BE 849475A BE 173320 A BE173320 A BE 173320A BE 173320 A BE173320 A BE 173320A BE 849475 A BE849475 A BE 849475A
- Authority
- BE
- Belgium
- Prior art keywords
- compositions
- preparation
- clavulanic acid
- etherified derivatives
- etherified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB51688/75A GB1573503A (en) | 1975-12-17 | 1975-12-17 | Clavulanic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BE849475A true BE849475A (fr) | 1977-06-16 |
Family
ID=10461003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE173320A BE849475A (fr) | 1975-12-17 | 1976-12-16 | Derives etherifies de l'acide clavulanique, leur preparation et compositions en contenant. |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5293792A (fr) |
AU (1) | AU2064576A (fr) |
BE (1) | BE849475A (fr) |
DE (1) | DE2657048A1 (fr) |
DK (1) | DK565676A (fr) |
FR (1) | FR2335222A1 (fr) |
GB (1) | GB1573503A (fr) |
NL (1) | NL7613965A (fr) |
SE (1) | SE7614181L (fr) |
ZA (1) | ZA767496B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7709876A (nl) * | 1976-09-09 | 1978-03-13 | Glaxo Lab Ltd | Werkwijze voor de bereiding van nieuwe (beta)-laktamen. |
GB1587612A (en) * | 1976-10-30 | 1981-04-08 | Beecham Group Ltd | Isoclavulanic acid derivatives |
GB1595176A (en) * | 1976-12-03 | 1981-08-12 | Beecham Group Ltd | Clavulanic acid ethers |
IL53465A (en) * | 1976-12-11 | 1980-11-30 | Beecham Group Ltd | Process for the preparation of clavulanic acid ethers and some novel compounds of this type |
NO771106L (no) * | 1977-03-10 | 1978-09-12 | Beecham Group Ltd | Fremgangsmaate for fremstilling av etere |
DE3062347D1 (en) * | 1979-08-11 | 1983-04-21 | Beecham Group Plc | Process for the preparation of derivatives of clavulanic acid |
GB9518917D0 (en) * | 1995-09-15 | 1995-11-15 | Smithkline Beecham Plc | Compounds |
-
1975
- 1975-12-17 GB GB51688/75A patent/GB1573503A/en not_active Expired
-
1976
- 1976-12-16 DK DK565676A patent/DK565676A/da unknown
- 1976-12-16 SE SE7614181A patent/SE7614181L/xx unknown
- 1976-12-16 BE BE173320A patent/BE849475A/fr not_active IP Right Cessation
- 1976-12-16 DE DE19762657048 patent/DE2657048A1/de not_active Withdrawn
- 1976-12-16 AU AU20645/76A patent/AU2064576A/en not_active Expired
- 1976-12-16 JP JP15038176A patent/JPS5293792A/ja active Pending
- 1976-12-16 NL NL7613965A patent/NL7613965A/xx not_active Application Discontinuation
- 1976-12-17 ZA ZA00767496A patent/ZA767496B/xx unknown
- 1976-12-17 FR FR7638152A patent/FR2335222A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2335222A1 (fr) | 1977-07-15 |
JPS5293792A (en) | 1977-08-06 |
DE2657048A1 (de) | 1977-06-23 |
ZA767496B (en) | 1978-02-22 |
AU2064576A (en) | 1978-06-22 |
DK565676A (da) | 1977-06-18 |
NL7613965A (nl) | 1977-06-21 |
FR2335222B1 (fr) | 1982-06-11 |
GB1573503A (en) | 1980-08-28 |
SE7614181L (sv) | 1977-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2331352A1 (fr) | Compositions stables d'erythrocytes, leur procede de preparation et leur application | |
FR2281340A1 (fr) | Derives de l'acide folique, leur procede de preparation et leur application | |
BE771493A (fr) | Nouveaux derives de l'isoindoline, leur preparation et les compositionsqui les contiennent | |
BE846081A (fr) | Nouveaux derives d'amidoximes, leur preparation et compositions en contenant | |
FR2347365A1 (fr) | Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant | |
BE838194A (fr) | Nouveaux derives de l'oxadiazolinone, leur preparation et les compositions qui les contiennent | |
FR2342335A1 (fr) | Perles d'auxiliaires de detergence, leur preparation et composition detergente les contenant | |
BE801246A (fr) | Nouveaux derives de l'acide quinaldique et leur preparation | |
BE803771A (fr) | Derives de l'acide 4-hydroxy-3,5-di-alcoyl-phenyl-propionique, leur preparation et leur application | |
FR2343730A1 (fr) | Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant | |
BE849475A (fr) | Derives etherifies de l'acide clavulanique, leur preparation et compositions en contenant. | |
BE753660A (fr) | Nouveaux derives de l'imidazole, leur preparation et les compositions medicinales qui les contiennent | |
BE848227A (fr) | Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant, | |
FR2290193A1 (fr) | Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant | |
FR2334681A1 (fr) | Nouveaux derives de l'acide lysergique et leur preparation | |
LU81182A1 (fr) | Nouveaux derives de l'isoquinoleine,leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2310132A1 (fr) | 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant | |
FR2340310A1 (fr) | Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant | |
BE846083A (fr) | Nouveaux derives de l'oxadiazine-1,2,4, one-5, leur preparation et compositions en contenant | |
BE860042A (fr) | Nouveaux derives de l'acide clavulanique, leur preparation et compositions en contenant. | |
FR2283670A1 (fr) | Derives d'acides 19,20-bis-nor-prostanoique, leur preparation et compositions pharmaceutiques les contenant | |
BE863802A (fr) | Nouveaux derives d'everninomicine, leur procedes de preparation et compositions pharmaceutiques contenant lesdits derives | |
BE849177A (fr) | Derives thiadiazolyliques de l'acide 7-acylamido-3-cepheme-4-carboxylique et leur preparation | |
BE799215A (fr) | Nouveaux derives de l'imino-isoindolinone utilisables comme pigments et leur preparation, | |
BE792803A (fr) | Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CH | Change of patent owner |
Owner name: *BEECHAM GROUP P.L.C. Effective date: 19841016 |
|
RE | Patent lapsed |
Owner name: BEECHAM GROUP P.L.C. Effective date: 19861231 |